Tocagen's Upswing, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
TOCAGEN INC COMMON (TOCA)
Last tocagen inc common earnings: 2/27 04:10 pm
Check Earnings Report
US:NASDAQ Investor Relations:
tocagen.com
Company Research
Source: Seeking Alpha
Summary Tocagen's merger-fueled upswing continues. Milestone Pharma declares full year earnings. Ardelyx plans to file its Tenapanor application by mid-2020. Tocagen Continues Merger-Fueled Upswing Tocagen ( TOCA Tocagen has a tumultuous history behind it. The stock suffered massive loss when its trials assessing the effectiveness of Toca FC and Toca 511 failed to meet the mark. The trial failed to achieve the primary endpoint of overall survival compared to standard-of-care treatment (median of 11.1 months vs. 12.2 months; hazard ratio: 1.06; p=0.6154). The secondary endpoints of the trial also failed to show any significant differences between the treatment arms. The aftermath of trial failure led to the company sacking nearly two thirds of its employees. The merger is expected to be finalized in the second quarter of the year. Tocagen CEO Marty Duvall said Forte Biosciences is currently privately held and post- Milestone Pharmaceuticals Reports Full Year And Q4 Numbers Milestone Ph
Show less
Read more
Impact Snapshot
Event Time:
TOCA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOCA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOCA alerts
High impacting TOCAGEN INC COMMON news events
Weekly update
A roundup of the hottest topics